company background image
BALAXI logo

Balaxi Pharmaceuticals NSEI:BALAXI Stock Report

Last Price

₹75.65

Market Cap

₹4.0b

7D

-2.6%

1Y

-9.6%

Updated

21 Nov, 2024

Data

Company Financials

Balaxi Pharmaceuticals Limited

NSEI:BALAXI Stock Report

Market Cap: ₹4.0b

BALAXI Stock Overview

Engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in India and internationally. More details

BALAXI fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health4/6
Dividends0/6

Rewards

Price-To-Earnings ratio (10.8x) is below the Indian market (31x)

Became profitable this year

Risk Analysis

High level of non-cash earnings

Does not have a meaningful market cap (₹4B)


Balaxi Pharmaceuticals Limited Competitors

QMS Medical Allied Services

NSEI:QMSMEDI

₹2.0b

Vasa Denticity

NSEI:DENTALKART

₹9.9b

Vaidya Sane Ayurved Laboratories

NSEI:MADHAVBAUG

₹1.5b

Remus Pharmaceuticals

NSEI:REMUS

₹13.9b

Price History & Performance

Summary of all time highs, changes and price drops for Balaxi Pharmaceuticals
Historical stock prices
Current Share Price₹75.65
52 Week High₹151.45
52 Week Low₹74.00
Beta0.74
11 Month Change-17.63%
3 Month Change-30.82%
1 Year Change-9.64%
33 Year Change-30.06%
5 Year Change388.38%
Change since IPO2,671.06%

Recent News & Updates

Balaxi Pharmaceuticals (NSE:BALAXI) Strong Profits May Be Masking Some Underlying Issues

Nov 13
Balaxi Pharmaceuticals (NSE:BALAXI) Strong Profits May Be Masking Some Underlying Issues

These 4 Measures Indicate That Balaxi Pharmaceuticals (NSE:BALAXI) Is Using Debt Reasonably Well

Jul 30
These 4 Measures Indicate That Balaxi Pharmaceuticals (NSE:BALAXI) Is Using Debt Reasonably Well

Recent updates

Balaxi Pharmaceuticals (NSE:BALAXI) Strong Profits May Be Masking Some Underlying Issues

Nov 13
Balaxi Pharmaceuticals (NSE:BALAXI) Strong Profits May Be Masking Some Underlying Issues

These 4 Measures Indicate That Balaxi Pharmaceuticals (NSE:BALAXI) Is Using Debt Reasonably Well

Jul 30
These 4 Measures Indicate That Balaxi Pharmaceuticals (NSE:BALAXI) Is Using Debt Reasonably Well

Balaxi Pharmaceuticals Limited's (NSE:BALAXI) Share Price Could Signal Some Risk

May 29
Balaxi Pharmaceuticals Limited's (NSE:BALAXI) Share Price Could Signal Some Risk

Market Might Still Lack Some Conviction On Balaxi Pharmaceuticals Limited (NSE:BALAXI) Even After 38% Share Price Boost

Feb 10
Market Might Still Lack Some Conviction On Balaxi Pharmaceuticals Limited (NSE:BALAXI) Even After 38% Share Price Boost

Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet

Feb 09
Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet

Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?

Aug 08
Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?

The Trend Of High Returns At Balaxi Pharmaceuticals (NSE:BALAXI) Has Us Very Interested

May 20
The Trend Of High Returns At Balaxi Pharmaceuticals (NSE:BALAXI) Has Us Very Interested

A Look At The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Feb 03
A Look At The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Calculating The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Sep 06
Calculating The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Balaxi Pharmaceuticals (NSE:BALAXI) Knows How To Allocate Capital Effectively

Jun 03
Balaxi Pharmaceuticals (NSE:BALAXI) Knows How To Allocate Capital Effectively

Is Weakness In Balaxi Pharmaceuticals Limited (NSE:BALAXI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Mar 12
Is Weakness In Balaxi Pharmaceuticals Limited (NSE:BALAXI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Is Balaxi Pharmaceuticals Limited's(NSE:BALAXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Nov 27
Is Balaxi Pharmaceuticals Limited's(NSE:BALAXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Shareholder Returns

BALAXIIN HealthcareIN Market
7D-2.6%0.8%0.3%
1Y-9.6%36.4%27.3%

Return vs Industry: BALAXI underperformed the Indian Healthcare industry which returned 36.4% over the past year.

Return vs Market: BALAXI underperformed the Indian Market which returned 27.3% over the past year.

Price Volatility

Is BALAXI's price volatile compared to industry and market?
BALAXI volatility
BALAXI Average Weekly Movement4.6%
Healthcare Industry Average Movement5.5%
Market Average Movement6.1%
10% most volatile stocks in IN Market9.2%
10% least volatile stocks in IN Market4.0%

Stable Share Price: BALAXI has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: BALAXI's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1942600Ashish Maheshwaribalaxipharma.in

Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in India and internationally. The company offers pharmaceutical products across various therapeutic areas that mainly treats antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpastes.

Balaxi Pharmaceuticals Limited Fundamentals Summary

How do Balaxi Pharmaceuticals's earnings and revenue compare to its market cap?
BALAXI fundamental statistics
Market cap₹4.02b
Earnings (TTM)₹355.97m
Revenue (TTM)₹2.64b

10.8x

P/E Ratio

1.5x

P/S Ratio

Is BALAXI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BALAXI income statement (TTM)
Revenue₹2.64b
Cost of Revenue₹1.42b
Gross Profit₹1.22b
Other Expenses₹862.64m
Earnings₹355.97m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)6.99
Gross Margin46.23%
Net Profit Margin13.50%
Debt/Equity Ratio14.1%

How did BALAXI perform over the long term?

See historical performance and comparison